Jyothy Labs Q2 FY27 results: net profit down 87.9% to ₹10.60 crore, revenue up 3.3%

How did Jyothy Labs perform in Q2 FY27?

Jyothy Labs reported standalone revenue of ₹760.04 crore in Q2 FY27, up 3.3% from ₹736.06 crore in Q2 FY26. EBITDA fell 83.8% to ₹19.17 crore, while the margin declined 13.6 percentage points to 2.5% from 16.1%. Total expenses were ₹759.29 crore, up 19.7% from ₹634.35 crore.

Profit before tax fell 86.2% to ₹16.38 crore from ₹118.69 crore, and net profit declined 87.9% to ₹10.60 crore from ₹87.76 crore. Basic EPS was ₹0.29 against ₹2.39. Against Q1 FY27, revenue fell 1.7%, EBITDA fell 70.4% and net profit fell 77.7%. The results are on a standalone basis.

What changed in Jyothy Labs' costs and profit?

Total expenses were ₹759.29 crore in Q2 FY27, up ₹124.94 crore from ₹634.35 crore in Q2 FY26. Cost of materials rose ₹70.97 crore to ₹454.75 crore, employee cost increased ₹4.85 crore to ₹89.62 crore, depreciation rose ₹1.89 crore to ₹17.09 crore and other expenses increased ₹4.84 crore to ₹155.49 crore. Finance costs fell ₹0.03 crore to ₹1.33 crore.

Other income was ₹15.63 crore, down ₹1.35 crore from ₹16.98 crore in the year-ago quarter. There was no exceptional item. Tax was ₹5.78 crore, down ₹25.15 crore from ₹30.93 crore, while profit before tax fell ₹102.31 crore to ₹16.38 crore. Management said crude-linked input inflation and higher raw-material and packaging costs pressured gross margin.

How did the first half of FY27 go?

In H1 FY27, Jyothy Labs reported revenue of ₹1,533.44 crore, up 3.1% from ₹1,487.27 crore in H1 FY26. Total income was ₹1,566.72 crore, up 2.8% from ₹1,523.69 crore. EBITDA margin was 5.5%, compared with 16.3% in the year-ago period.

Profit before tax fell 67.0% to ₹81.36 crore from ₹246.22 crore, while net profit declined 68.4% to ₹58.24 crore from ₹184.55 crore. Basic EPS was ₹1.59, down from ₹5.03. The results are on a standalone basis.

What do the balance sheet and cash flow show?

Total assets were ₹2,123.25 crore at 30 September 2026, compared with ₹2,252.36 crore at 31 March 2026. Total equity was ₹1,517.11 crore, down from ₹1,588.61 crore. The company reported no borrowings at either date, while cash fell to ₹22.12 crore from ₹52.59 crore.

Inventories rose to ₹428.35 crore from ₹344.41 crore, trade receivables fell to ₹183.52 crore from ₹256.6 crore, and trade payables declined to ₹285.48 crore from ₹316.64 crore. In H1 FY27, operating cash flow was negative ₹12.83 crore, against ₹196.45 crore in H1 FY26; investing cash flow was ₹127.14 crore against negative ₹117.42 crore.

How has Jyothy Labs done over the last 8 quarters?

Revenue rose year on year in each of the last eight quarters. It reached ₹773.40 crore in Q1 FY27 before easing to ₹760.04 crore in Q2 FY27; the highest quarterly revenue in the series shown was ₹773.40 crore and the lowest was ₹665.96 crore.

Net profit moved from ₹96.79 crore in Q1 FY26 to ₹87.76 crore, ₹81.12 crore, ₹67.52 crore, ₹47.64 crore and ₹10.60 crore in the following quarters. EBITDA margin fell from 16.8% in Q4 FY25 to 2.5% in Q2 FY27, its lowest level in the series shown, after peaking at 16.8%.

Which businesses drove the quarter?

Fabric Care reported revenue of ₹386.58 crore in Q2 FY27, up 15.2% from ₹335.47 crore in Q2 FY26. Segment EBIT was ₹23.88 crore, down from ₹73.65 crore, and the reported EBIT margin was 6.2%.

Home Care reported revenue of ₹282.38 crore and an EBIT loss of ₹12.83 crore, with a margin of negative 4.5%. No year-ago revenue, EBIT or growth figure was provided for this segment. Personal Care reported revenue of ₹91.08 crore, up 11.2% from ₹81.93 crore, and EBIT of ₹5.56 crore against ₹2.2 crore; its EBIT margin was 6.1%.

What else did the company announce?

The promoter and promoter group expressed their intention not to participate in the buyback. The board formed a buyback committee and delegated the necessary powers to it. The record date for eligible shareholders was 11 November 2026. No dividend, fund raise or appointment was reported in the same-day filings.

What did Jyothy Labs' management say?

Management said underlying Q2 value and volume growth, excluding Pril and Fa, was 12.4% and 8.1%. The company expects underlying business growth to remain healthy in Q3, led by fabric care, while gross margin is likely to remain under pressure. Management said a full H2 recovery cannot be assumed unless commodity prices moderate and remain stable.

Management offered no numerical FY27 revenue or EBITDA-margin guidance and described FY27 as an aberration year. It expects a full-year effective tax rate of 25–26% and said net working capital should return to 18–20 days. The dividend payout policy remains 35–50% of profits. Management identified crude-linked inputs, commodity inflation, affordability, rural demand and working-capital requirements as risks.

The Chairperson and Managing Director said: “We recognize that this level of profitability is significantly below our expectations.” She also said: “However, gross margins are likely to remain under pressure, and a full recovery in H2 cannot be assumed unless the commodity prices moderate and remain stable.” Management did not report a formal guidance change.

How did Jyothy Labs shares react?

After the filing appeared, the Jyothy Labs share price was up 1.7% after five minutes, 1.1% after 15 minutes and 3.6% after 30 minutes. It closed 0.1% lower from the previous close. The Household Products industry median rose 0.9% on the reaction day, so Jyothy Labs underperformed the sector by 1.0 percentage point.

Earlier reaction-day moves were mixed: the stock fell 2.2% on 12 August 2026 and 0.4% on 4 May 2026, rose 2.6% on 9 February 2026, fell 1.8% on 12 November 2025 and rose 1.8% on 12 August 2025. No one-day or five-day post-result close was available in the filing data.